Literature DB >> 23139386

Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome.

Ali M Al-Radaideh1, Samuel J Wharton, Su-Yin Lim, Christopher R Tench, Paul S Morgan, Richard W Bowtell, Cris S Constantinescu, Penny A Gowland.   

Abstract

OBJECTIVE: To determine, using ultra-high field magnetic resonance imaging (MRI), whether changes in iron content occur in the earliest phases of demyelinating disease, by quantifying the magnetic susceptibility of deep grey matter structures in patients with Clinically Isolated Syndrome (CIS) that is suggestive of multiple sclerosis (MS), as compared with age-matched healthy subjects.
METHODS: We compared 19 CIS patients to 20 age-matched, healthy controls. Scanning of the study subjects was performed on a 7T Philips Achieva system, using a 3-dimensional, T2*-weighted gradient echo acquisition. Phase data were first high-pass filtered, using a dipole fitting method, and then inverted to produce magnetic susceptibility maps. Region of interest (ROI) analysis was used to estimate magnetic susceptibility values for deep grey matter structures (caudate nucleus, putamen, globus pallidus, the thalamus and its pulvinar).
RESULTS: Significantly increased relative susceptibilities were found in the CIS group, compared with controls, for the caudate nucleus (p = < 0.01), putamen (p < 0.01), globus pallidus (p < 0.01) and pulvinar (p < 0.05). We found no significant nor consistent trends in the relationship between susceptibility and age for either the study controls or CIS patients, in any ROI (r(2) < 0.5; p > 0.05). In CIS patients, the time elapsed since the clinical event and the Expanded Disability Status Scale (EDSS) scores were not correlated with iron levels in any ROI (r(2) < 0.5; p > 0.05); however, a moderate correlation (r(2) = 0.3; p < 0.01) was found between the T1 lesion load and the mean susceptibility of the caudate nucleus.
CONCLUSION: CIS patients showed an increased iron accumulation, as measured using susceptibility mapping of the deep grey matter, suggesting that iron changes did occur at the earlier stages of CIS disease.

Entities:  

Keywords:  Clinically Isolated Syndrome; Deep grey matter; brain regions; demyelinating disease; early MS; iron; magnetic resonance imaging; susceptibility mapping; ultra-high field

Mesh:

Substances:

Year:  2012        PMID: 23139386     DOI: 10.1177/1352458512465135

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  35 in total

Review 1.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders.

Authors:  Niels Bergsland; Eleonora Tavazzi; Ferdinand Schweser; Dejan Jakimovski; Jesper Hagemeier; Michael G Dwyer; Robert Zivadinov
Journal:  CNS Drugs       Date:  2019-11       Impact factor: 5.749

Review 3.  Perspectives of Ultra-High-Field MRI in Neuroradiology.

Authors:  E R Gizewski; C Mönninghoff; M Forsting
Journal:  Clin Neuroradiol       Date:  2015-07-17       Impact factor: 3.649

Review 4.  Introduction to Quantitative Susceptibility Mapping and Susceptibility Weighted Imaging.

Authors:  Pascal P R Ruetten; Jonathan H Gillard; Martin J Graves
Journal:  Br J Radiol       Date:  2019-07-26       Impact factor: 3.039

5.  Hemoglobin as a source of iron overload in multiple sclerosis: does multiple sclerosis share risk factors with vascular disorders?

Authors:  Vladimir V Bamm; George Harauz
Journal:  Cell Mol Life Sci       Date:  2014-02-07       Impact factor: 9.261

6.  Early silent microstructural degeneration and atrophy of the thalamocortical network in multiple sclerosis.

Authors:  Michael Deppe; Julia Krämer; Jan-Gerd Tenberge; Jasmin Marinell; Wolfram Schwindt; Katja Deppe; Sergiu Groppa; Heinz Wiendl; Sven G Meuth
Journal:  Hum Brain Mapp       Date:  2016-02-27       Impact factor: 5.038

7.  A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclerosis.

Authors:  Robert Zivadinov; Michael Dwyer; Silva Markovic-Plese; Brooke Hayward; Niels Bergsland; Mari Heininen-Brown; Ellen Carl; Cheryl Kennedy; Fernando Dangond; Bianca Weinstock-Guttman
Journal:  Ther Adv Neurol Disord       Date:  2015-03       Impact factor: 6.570

8.  Blood circulating microparticle species in relapsing-remitting and secondary progressive multiple sclerosis. A case-control, cross sectional study with conventional MRI and advanced iron content imaging outcomes.

Authors:  J S Alexander; R Chervenak; B Weinstock-Guttman; I Tsunoda; M Ramanathan; N Martinez; S Omura; F Sato; G V Chaitanya; A Minagar; J McGee; M H Jennings; C Monceaux; F Becker; U Cvek; M Trutschl; R Zivadinov
Journal:  J Neurol Sci       Date:  2015-05-28       Impact factor: 3.181

9.  Quantitative Susceptibility Mapping of the Thalamus: Relationships with Thalamic Volume, Total Gray Matter Volume, and T2 Lesion Burden.

Authors:  G C Chiang; J Hu; E Morris; Y Wang; S A Gauthier
Journal:  AJNR Am J Neuroradiol       Date:  2018-01-25       Impact factor: 3.825

Review 10.  [Ultrahigh field MRI in context of neurological diseases].

Authors:  J Kuchling; T Sinnecker; I Bozin; J Dörr; V I Madai; J Sobesky; T Niendorf; F Paul; J Wuerfel
Journal:  Nervenarzt       Date:  2014-04       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.